Adult
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Aged
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
AIDS-Related Opportunistic Infections
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Antiretroviral Therapy, Highly Active
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Female
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Hepatitis C
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
HIV Infections
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Humans
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Male
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Middle Aged
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Patient Acceptance of Health Care
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.
Risk Factors
D. Ripamonti, Arici, C., Pezzotti, P., Maggiolo, F., Ravasio, L., and Suter, F.,
“Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.”,
AIDS (London, England), vol. 18, no. 2, pp. 334-7, 2004.